Efficacy of parenteral vaccination against porcine circovirus type 2 (PCV2) in seropositive piglets

Canadian Journal of Veterinary Research

Volumn 76, Issue 4, 2012, Pages 301-307

  Gamage, Lakshman N A ^a   Mcintosh, Kathleen A ^a   Parker, Sarah ^a   Harding, John ^a   Krakowka, Steven ^b   Ellis, John ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCOVIRUS TYPE 2 VACCINE; MATERNAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BIOLOGICAL MONITORING; BODY WEIGHT; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFECTIOUS ARTHRITIS; INGUINAL LYMPH NODE; INOCULATION; LOADING DRUG DOSE; LYMPHOID HYPERPLASIA; MATERNAL AGE; MESENTERY LYMPH NODE; NONHUMAN; PIGLET; PORCINE CIRCOVIRUS TYPE 2; SERODIAGNOSIS; SIGNAL TRANSDUCTION; TISSUE HOMOGENATE; VACCINATION;

ADAPTIVE IMMUNITY; ANIMALS; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOHISTOCHEMISTRY; LYMPH NODES; SWINE; SWINE DISEASES; VACCINATION; VIRAL VACCINES;

PORCINE CIRCOVIRUS 2; SUIDAE;

EID: 84868139427     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hamel AL, Lin LL, Nayar GP. Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. J Virol 1998;72:5262-5267.
2. Ellis J, Krakowka S, Lairmore M, et al. Reproduction of lesions of postweaning multisystemic wasting syndrome in gnotobiotic piglets. J Vet Diagn Invest 1999;11:3-14.
3. Harding JC. The clinical expression and emergence of porcine circovirus 2. Vet Microbiol 2004;98:131-135.
4. Thomson J, Smith B, Allan G, McNeilly F, McVicar C. PDNS, PMWS and porcine circovirus type 2 in Scotland. Porcine der- matitis and nephropathy syndrome. Post-weaning multisystemic wasting syndrome. Vet Rec 2000;146:651-652.
5. Bogdan J, West K, Clark E, et al. Association of porcine circo- virus 2 with reproductive failure in pigs: A retrospective study, 1995-1998. Can Vet J 2001;42:548-550.
6. Grau-Roma L, Segalés J. Detection of porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, swine influenza virus and Aujeszky's disease virus in cases of porcine proliferative and necrotizing pneumonia (PNP) in Spain. Vet Microbiol 2007;119:144-151.
7. Kim J, Chung HK, Chae C. Association of porcine circovi- rus 2 with porcine respiratory disease complex. Vet J 2003;166: 251-256.
8. Harding JC, Baker CD, Tumber A, et al. Porcine circovirus-2 DNA concentration distinguishes wasting from nonwasting pigs and is correlated with lesion distribution, severity, and nucleocapsid staining intensity. J Vet Diagn Invest 2008;20:274-282.
9. Carman S, McEwen B, DeLay J, et al. Porcine circovirus-2 associated disease in swine in Ontario (2004 to 2005). Can Vet J 2006;47:761-762.
10. Allan GM, Phenix KV, Todd D, McNulty MS. Some biological and physico-chemical properties of porcine circovirus. Zentralbl Veterinarmed B 1994;41:17-26.
11. Fort M, Sibila M, Allepuz A, Mateu E, Roerink F, Segalés J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different geno- types and geographic origins. Vaccine 2008;26:1063-1071.
12. Kixmoller M, Ritzmann M, Eddicks M, Saalmuller A, Elbers K, Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008; 26:3443-3451.
13. McKeown NE, Opriessnig T, Thomas P, et al. Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2. Clin Diagn Lab Immunol 2005;12:1347-1351.
14. Parreno V, Hodgins DC, de Arriba L, et al. Serum and intestinal isotype antibody responses to Wa human rotavirus in gnoto- biotic pigs are modulated by maternal antibodies. J Gen Virol 1999;80:1417-1428.
15. McIntosh KA, Harding JCS, Ellis JA, Appleyard GD. Detection of Porcine circovirus type 2 viremia and seroconversion in natu- rally infected pigs in a farrow-to-finish barn. Can J Vet Res 2006; 70:58-61.
16. Harding J. Different approaches to handling Circovirus. In: Proceedings of the London Swine Conference: Thinking Globally, Acting Locally; London, Ontario, 2006:35-40.
17. Salmon H, Berri M, Gerdts V, Meurens F. Humoral and cellular factors of maternal immunity in swine. Dev Comp Immunol 2009;33:384-393.
18. Meerts P, Van Gucht S, Cox E, Vandebosch A, Nauwynck HJ. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunol 2005;18:333-341.
19. Desrosiers R. PRRS and PCV2 infections, interactions and control. In: Proceedings of the Annual Meeting of the Western Canadian Association of Swine Veterinarians; 2009 Oct 16-17; Saskatoon, Saskatchewan; 2009:63-87.
20. Allan GM, Mackie DP, McNair J, Adair BM, McNulty MS. Production, preliminary characterisation and applications of monoclonal antibodies to porcine circovirus. Vet Immunol Immunopathol 1994;43:357-371.
21. McNeilly F, McNair I, Mackie DP, et al. Production, characterisation and applications of monoclonal antibodies to porcine circovirus 2. Arch Virol 2001;146:909-922.
22. McNeilly F, McNair I, O'Connor M, et al. Evaluation of a por- cine circovirus type 2-specific antigen-capture enzyme-linked immuno sorbent assay for the diagnosis of postweaning multi- systemic wasting syndrome in pigs: Comparison with virus isolation, immunohistochemistry, and the polymerase chain reaction. J Vet Diagn Invest 2002;14:106-112.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
24. Dulac GC, Afshar A. Porcine circovirus antigens in PK-15 cell line (ATCC CCL-33) and evidence of antibodies to circovirus in Canadian pigs. Can J Vet Res 1989;53:431-433.
25. Tischer I, Peters D, Rasch R, Pociuli S. Replication of porcine circovirus: induction by glucosamine and cell cycle dependence. Arch Virol 1987;96:39-57.
26. Walker IW, Konoby CA, Jewhurst VA, et al. Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2. J Vet Diagn Invest 2000;12:400-405.
27. Rodriguez-Arrioja GM, Segalés J, Balasch M, et al. Serum anti- bodies to porcine circovirus type 1 and type 2 in pigs with and without PMWS. Vet Rec 2000;146:762-764.
28. Opriessnig T, Yu S, Thacker EL, Halbur PG. Deprivation of porcine circovirus type 2-negative pigs from positive breeding herds. J Swine Health Prod 2004;12:186-191.
29. Glass EJ. Genetic variation and responses to vaccines. Anim Health Res Rev 2004;5:197-208.
30. Grindstaff JL, Brodie ED, Ketterson ED. Immune function across generations: Integrating mechanism and evolutionary process in maternal antibody transmission. Proc Biol Sci 2003; 270:2309-2319.
31. Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: Review of hypotheses and definition of main determinants. Vaccine 2003;21:3406-3412.
32. Getahun A, Heyman B. Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: Evidence for epitope masking and decreased localization of antigen in the spleen. Scand J Immunol 2009;70:277-287.
33. Song Y, Jin M, Zhang S, et al. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2. Vet Microbiol 2007;119:97-104.
34. Opriessnig T, Madson DM, Prickett JR, et al. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection. Vet Microbiol 2008;131:103-114.
35. Krakowka S, Ellis J, McNeilly F, Waldner C, Allan G. Features of porcine circovirus-2 disease: Correlations between lesions, amount and distribution of virus, and clinical outcome. J Vet Diagn Invest 2005;17:213-222.
36. Balasch M, Segalés J, Rosell C, et al. Experimental inoculation of conventional pigs with tissue homogenates from pigs with post-weaning multisystemic wasting syndrome. J Comp Pathol 1999;121:139-148.
37. Zhu Y, Lau A, Lau J, Jia Q, Karuppannan AK, Kwang J. Enhanced replication of porcine circovirus type 2 (PCV2) in a homogeneous subpopulation of PK15 cell line. Virology 2007;369:423-430.
38. Allan GM, McNeilly F, Ellis J, et al. Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication. Arch Virol 2000;145:2421-2429.
39. Resendes A, Segalés J, Balasch M, et al. Lack of an effect of a commercial vaccine adjuvant on the development of postweaning multisystemic wasting syndrome (PMWS) in porcine circovirus type 2 (PCV2) experimentally infected conventional pigs. Vet Res 2004;35:83-90.
40. Hasslung F, Wallgren P, Ladekjaer-Hansen AS, et al. Experimental reproduction of postweaning multisystemic wasting syndrome (PMWS) in pigs in Sweden and Denmark with a Swedish isolate of porcine circovirus type 2. Vet Microbiol 2005;106:49-60.